Skip to main content

Table 1 Clinical features of the patient with jaundice

From: Identification of a novel splicing mutation in the SLC25A13 gene from a patient with NICCD: a case report

Index Test result Range
Blood cell counting
 WBC 15.80 × 109/L 3.5–9.5 × 109/L
 RBC 3.63 × 1012/L 3.8–5.1 × 1012/L
 PLT 359.0 × 109/L 125.0–350.0 × 109/L
 Hb 94.0 g/L 115.0–150.0 g/L
Blood biochemistry
 GLU 3.80 mmol/L 4.1–6.5 mmol/L
 LAC 5.25 mmol/L 0.5–2.2 mmol/L
 ALT 65 U/L 4–33 U/L
 AST 160 U/L 4–32 U/L
 TBIL 156.6 μmol/L 3.4–20.5 μmol/L
 DBIL 121.6 μmol/L 0–10 μmol/L
 IBIL 35.0 μmol/L 1.5–16.5 μmol/L
 TG 3.08 mmol/L 0.05–1.7 mmol/L
 TBA 210.6 μmol/L 1.0–10 μmol/L
 BUA 198.6 μmol/L 142.8–339.2 μmol/L
 BA 57 μmol/L 18–72 μmol/L
 PCT 2.92 ng/mL 0.02–0.05 ng/mL
 AFP 47,328 ng/mL <  25 ng/mL
Immunology
 IgA 0.13 g/L 0.82–4.53 g/L
 IgG 5.50 g/L 6.6–17.5 g/L
 IgM 0.66 g/L 0.46–3.04 g/L
 C3 0.54 g/L 0.16–0.38 g/L
 C4 0.11 g/L 0.22–0.58 g/L
  1. WBC White blood cell, RBC Red blood cell, PLT Platelet, Hb hemoglobin, GLU Blood glucose, LAC Lactic acid, ALT glutamic-pyruvic transaminase, AST Glutamic oxalacetic transaminase, TBIL Total bilirubin, DBIL Direct bilirubin, IBIL Indirect bilirubin, TG Triglyceride, TBA Total bile acid, BUA Blood uric acid, BA blood ammonia, PCT Procalcitonin, AFP alpha fetoprotein